Mumps virus vaccine, live

RUBELLA AND MUMPS VIRUS VACCINE, LIVE (Biavax II)... 

Measles, Mumps, Rubella, Varicella Virus Vaccine, Live [MMRV] (Proquad) Meningococcal Conjugate Vaccine (Menactra) Meningococcal Polysaccharide Vaccine (Menomune A/C/YAV-135) Pneumococcal 7-Valent Conjugate Vaccine (Prevnar)... 

Live mumps virus vaccine is available in monovalent (mumps only) form and in combination with measles... 

MEASLES, MUMPS, AND RUBELLA VIRUS VACCINE, LIVE... 

Antibodies in the immune globulin preparations may interfere with the immune response to live virus vaccines, particularly measles, but also others, such as mumps and rubella It is recommended that the live virus vaccines be administered 14 to 30 days before or 6 to 12 weeks after administration of immune globulins. No known interactions have been reported with antivenins. 

Measles, mumps, and rubella vaccine is a live virus vaccine that should be used with caution in immunosuppressed children, such as those with cancer receiving chemotherapy, solid organ or bone marrow transplantation, or receiving other immunosuppressive drugs, such as steroids in a dose... 

Mumps vaccine Live attenuated strain of the mumps virus Paramyxovirus parotitidus) Active immunization against mumps... 

Live attenuated virus vaccines for measles, mumps and rubella (MMR) have been combined into a single vaccine known as MMR vaccine. The MMR vaccine is effective as the single-virus vaccine composed of the respective strains and has been shown to be highly effective. The immunity induced by MMR is long lasting and may be lifelong. 

Mumps Live virus Subcutaneous One dose None Adults born after 1956 without a history of mumps or live virus vaccination on or after their first birthday... 

Live measles virus vaccine is available in monovalent (measles only) form and in combinations measles-rubella (MR) and measles-mumps-rubella (MMR) vaccines. Measles vaccines based on further attenuated strains (beyond the level of the original strain, for example the Edmonston B strain or Schwarz strain) produces a mild or subclinical and non-communicable infection. 

Immunocompromise is a contraindication to the use of live virus vaccines, such as measles, mumps, rubella, and oral poliomyelitis vaccine. It is recommended that rubella or MMR vaccine should not be given to persons who are immunosuppressed because of AIDS or other clinical manifestations of HIV infection. The vaccine can be given to asymptomatic infected people (139). 

Mumps virus infects the parotid glands to cause swelling and a general viraemia. Complications include pancreatitis, meningitis and orchitis, the latter occasionally leading to male sterility. Infections can also cause permanent unilateral deafness at any age. In the absence of vaccination, infection occurs in >90 % of individuals by age 15 years. A live attenuated mumps vaccine has been available since 1967... 

IGIM should be injected into a deltoid or gluteal muscle. It does not affect the immune response of inactivated vaccines, oral polio virus, or yellow fever vaccine. The administration of live vaccines [e.g., measles, mumps, rubella (MMR) vaccine] concomitantly with IGIM may decrease the immune response significantly thus, MMR and varicella vaccine should be delayed for at least 3 and 5 months, respectively, after IGIM has been administered. Additionally, IGIM should not be given within 2 weeks of the MMR administration or within 3 weeks of the varicella vaccine to maximize the efficacy of the immunization.1... 

Since the introduction of the mumps vaccine in 1967 there has been a 99% reduction in reported cases. The mumps vaccine is a live virus preparation of the leryl-Lynn strain. It produces a sub-clinical, non-communicable infection following vaccination. Single doses of mumps vaccine will elicit immunity in 75% to 95% of individuals. Vaccine-induced immunity lasts for more than 30 years. 

Currently available live vaccines include measles, mumps, polio, rubella, vaccinia (smallpox), varicella (chickenpox), and yellow fever. All of these are made from viruses. There are two live bacterial vaccines 1) Bacillus of Calmette and Guerin (BCG) vaccine for tuberculosis and 2) oral typhoid. 

A trivalent vaccine containing the live attenuated viruses for measles, mumps and rubella was first introduced in the United States in the early 1970s by Merck and Co Inc. Since that time, other triple vaccines have been developed using various different viral strains and many coim-tiies have licensed them either as the sole vaccine... 

Live attenuated viruses, e.g. measles, mumps and yellow fever viral vaccines. 

Many of the more prominent vaccine preparations in current medical use consist of attenuated viral particles (Table 10.11). Mumps vaccine consists of live attenuated strains of Paramyxovirus parotitidis. In many world regions, it is used to routinely vaccinate children, often a part of a combined measles, mumps and rubella (MMR) vaccine. Several attenuated strains have been developed for use in vaccine preparations. The most commonly used is the Jeryl Linn strain of the mumps vaccine, which is propagated in chick embryo cell culture. This vaccine has been administered to well over 50 million people worldwide and, typically, results in seroconversion rates of over 97%. The Sabin (oral poliomyelitis) vaccine consists of an aqueous suspension of poliomyelitis virus, usually grown in cultures of monkey kidney tissue. It contains approximately 1 million particles of poliomyelitis strains 1, 2 or 3 or a combination of all three strains. 

The most notable example of live attenuated vaccines is the smallpox vaccine, first developed by Edward Jenner, although the origin of the vaccine (vaccinia virus) remains obscure. More recent examples of live attenuated vaccines include most of the viral vaccines currently in use, such as measles/mumps/rubella (MMR) and varicella zoster (VZV) vaccines, and some... 

AZATHIOPRINE VACCINES i effectiveness of vaccines, t risk of adverse/toxic effects of live vaccines (e.g. measles, mumps, rubella, oral polio, BCG, yellow fever, varicella, TY21a typhoid), e.g. vaccinal infections Disseminated infection due to enhanced replication of vaccine virus in the presence of diminished immunocompetence Do not vaccinate when patients are on immunosuppressants. Vaccination should be deferred for at least 3 months after discontinuing immunosuppressants/myelosuppres-sants. If an individual has been recently vaccinated, do not initiate therapy for at least 2 weeks after vaccination... 

---